logo

1.71

1.71 (-2.80%)

As of Mar 06, 2024

Passage Bio, Inc. [PASG]

Source: 

Company Overview

Passage Bio, Inc. is a clinical stage genetic medicines company focused on developing transformative therapies for CNS disorders. Our vision is to finally fulfill the promise of gene therapy by developing groundbreaking therapies that transform the lives of patients with CNS diseases.

CountryUnited States
Headquartersphiladelphiapennsylvania
Phone Number2678660312
Industry
manufacturing
CEODr. Bruce Goldsmith
Websitewww.clinicaltrials.gov